Corcept Therapeutics Incorporated · NASDAQ:CORT
Maduck Sean sold 25,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Jun 1 to Jun 2, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 2, 2026, Maduck Sean (See Remarks) sold 25,000 Corcept Therapeutics Incorporated shares at an average US$70.21 for US$1.76M under a trading plan, leaving 9,755 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$70.21 average (US$70.11 to US$70.75)
- Value
- US$1.76M
- Holding after
- 9,755 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 25,000 | US$8.27 | 33,977 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 21,069 | US$70.11 | 12,908 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 3,931 | US$70.75 | 8,977 | Direct |
| Jun 1, 2026 | Common Stock | Award | 615 | US$70.44 | 9,592 | Direct |
| Jun 1, 2026 | Common Stock | Award | 615 | 10,207 | Direct | |
| Jun 2, 2026 | Common Stock | Shares withheld for tax | 452 | US$70.44 | 9,755 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Maduck Sean
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Maduck Sean · Sep 3, 2026
- Form 4 · Maduck Sean · Aug 27, 2026
- Form 4 · Maduck Sean · Aug 18, 2026
- Form 4 · Maduck Sean · Aug 12, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026